Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Gunnar R. Leitner, Tyler J. Wenzel, Nick Marshall, Ellen J. Gates & Andis Klegeris. (2019) Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders. Expert Opinion on Therapeutic Targets 23:10, pages 865-882.
Read now
Read now
Juan Jose de la Cruz, Liliana Villanueva-Lizama, Victor Dzul-Huchim, María-Jesus Ramírez-Sierra, Pedro Martinez-Vega, Miguel Rosado-Vallado, Jaime Ortega-Lopez, Claudia Ivonne Flores-Pucheta, Portia Gillespie, Bin Zhan, Maria Elena Bottazzi, Peter J. Hotez & Eric Dumonteil. (2019) Production of recombinant TSA-1 and evaluation of its potential for the immuno-therapeutic control of Trypanosoma cruzi infection in mice. Human Vaccines & Immunotherapeutics 15:1, pages 210-219.
Read now
Read now
Lucian Visan, Violette Sanchez, Margaux Kania, Aymeric de Montfort, Luis M. de la Maza & Salvador Fernando Ausar. (2016) Phosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatis. Human Vaccines & Immunotherapeutics 12:9, pages 2341-2350.
Read now
Read now
Thomas R Kosten & Coreen B Domingo. (2013)
Can you vaccinate against substance abuse?
. Expert Opinion on Biological Therapy 13:8, pages 1093-1097.
Read now
Read now
Gregory C Ireton & Steven G Reed. (2013) Adjuvants containing natural and synthetic Toll-like receptor 4 ligands. Expert Review of Vaccines 12:7, pages 793-807.
Read now
Read now
David A Johnson. (2013) TLR4 agonists as vaccine adjuvants: a chemist’s perspective. Expert Review of Vaccines 12:7, pages 711-713.
Read now
Read now
Eric Dumonteil, Maria Elena Bottazzi, Bin Zhan, Michael J Heffernan, Kathryn Jones, Jesus G Valenzuela, Shaden Kamhawi, Jaime Ortega, Samuel Ponce de Leon Rosales, Bruce Y Lee, Kristina M Bacon, Bernhard Fleischer, BT Slingsby, Miguel Betancourt Cravioto, Roberto Tapia-Conyer & Peter J Hotez. (2012) Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects. Expert Review of Vaccines 11:9, pages 1043-1055.
Read now
Read now
Pamela Beatty, Sarangarajan Ranganathan & Olivera J. Finn. (2012) Prevention of colitis-associated colon cancer using a vaccine to target abnormal expression of the MUC1 tumor antigen. OncoImmunology 1:3, pages 263-270.
Read now
Read now
Holly Sanders & Ian M Feavers. (2011) Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines. Expert Review of Vaccines 10:3, pages 323-334.
Read now
Read now
Articles from other publishers (66)
Taku Tsukidate, Charles W. Hespen & Howard C. Hang. (2023) Small molecule modulators of immune pattern recognition receptors. RSC Chemical Biology 4:12, pages 1014-1036.
Crossref
Crossref
Duc Minh Nguyen, Cristina Poveda, Jeroen Pollet, Fabian Gusovsky, Maria Elena Bottazzi, Peter J. Hotez & Kathryn Marie Jones. (2023) The impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection. PLOS Neglected Tropical Diseases 17:11, pages e0011519.
Crossref
Crossref
Nathalie Garçon & Martin Friede. 2023. Plotkin's Vaccines. Plotkin's Vaccines
77
90.e4
.
Holger Heine & Alla Zamyatina. (2022) Therapeutic Targeting of TLR4 for Inflammation, Infection, and Cancer: A Perspective for Disaccharide Lipid A Mimetics. Pharmaceuticals 16:1, pages 23.
Crossref
Crossref
Patrick Syntin, Fabienne Piras-Douce, François Dalençon, Marie Garinot & Jean Haensler. (2022) Nonclinical safety assessments of a novel synthetic toll-like receptor 4 agonist and saponin based adjuvant. Toxicology and Applied Pharmacology, pages 116358.
Crossref
Crossref
Archana Gopalakrishnan, Katharina Richard, Rezwanul Wahid, Regina Harley, Marcelo B. Sztein, Lynn D. Hawkins & Stefanie N. Vogel. (2022) E6020, a TLR4 Agonist Adjuvant, Enhances Both Antibody Titers and Isotype Switching in Response to Immunization with Hapten-Protein Antigens and Is Diminished in Mice with TLR4 Signaling Insufficiency. The Journal of Immunology 209:10, pages 1950-1959.
Crossref
Crossref
Victor Manuel Dzul-Huchim, Maria Jesus Ramirez-Sierra, Pedro Pablo Martinez-Vega, Miguel Enrique Rosado-Vallado, Victor Ermilo Arana-Argaez, Jaime Ortega-Lopez, Fabian Gusovsky, Eric Dumonteil, Julio Vladimir Cruz-Chan, Peter Hotez, María Elena Bottazzi & Liliana Estefania Villanueva-Lizama. (2022) Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in chronically-infected BALB/c mice. PLOS Neglected Tropical Diseases 16:9, pages e0010258.
Crossref
Crossref
Colin N. Haile, Kurt J. Varner, Xia Huijing, Reetakshi Arora, Frank M. Orson, Thomas R. Kosten & Therese A. Kosten. (2022) Active and Passive Immunization with an Anti-Methamphetamine Vaccine Attenuates the Behavioral and Cardiovascular Effects of Methamphetamine. Vaccines 10:9, pages 1508.
Crossref
Crossref
Xiaoqiang Wu & Wanfang Li. (2022)
The applications of
β
‐keto amides for heterocycle synthesis
. Journal of Heterocyclic Chemistry 59:9, pages 1445-1490.
Crossref
Crossref
Sebastian Strobl, Karin Hofbauer, Holger Heine & Alla Zamyatina. (2022) Lipid A Mimetics Based on Unnatural Disaccharide Scaffold as Potent TLR4 Agonists for Prospective Immunotherapeutics and Adjuvants. Chemistry – A European Journal 28:35.
Crossref
Crossref
Pilar Garcia-Vello, Flaviana Di Lorenzo, Daniele Zucchetta, Alla Zamyatina, Cristina De Castro & Antonio Molinaro. (2022) Lipopolysaccharide lipid A: A promising molecule for new immunity-based therapies and antibiotics. Pharmacology & Therapeutics 230, pages 107970.
Crossref
Crossref
Virgil Schijns, Dragomira Majhen, Peter van der Ley, Aneesh Thakur, Artur Summerfield, Rita Berisio, Cristina Nativi, Alberto Fernández-Tejada, Carmen Alvarez-Dominguez, Sveinbjörn Gizurarson, Alla Zamyatina, Antonio Molinaro, Camillo Rosano, Žiga Jakopin, Ihsan Gursel & Siobhán McClean. (2021) Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation. Pharmaceutics 13:4, pages 501.
Crossref
Crossref
Holger Heine, Florian Adanitsch, Tina Tinkara Peternelj, Mira Haegman, Christoph Kasper, Simon Ittig, Rudi Beyaert, Roman Jerala & Alla Zamyatina. (2021) Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics. Frontiers in Immunology 12.
Crossref
Crossref
Jinny Claire Lee & Kim D. Janda. (2021) Immunopharmacotherapeutic advancements in addressing methamphetamine abuse. RSC Chemical Biology 2:1, pages 77-93.
Crossref
Crossref
Alla Zamyatina & Holger Heine. (2020) Lipopolysaccharide Recognition in the Crossroads of TLR4 and Caspase-4/11 Mediated Inflammatory Pathways. Frontiers in Immunology 11.
Crossref
Crossref
Liliana E. Villanueva‐Lizama, Julio V. Cruz‐Chan, Leroy Versteeg, Christian F. Teh‐Poot, Kristyn Hoffman, April Kendricks, Brian Keegan, Jeroen Pollet, Fabian Gusovsky, Peter J. Hotez, Maria Elena Bottazzi & Kathryn M. Jones. (2020)
TLR4 agonist protects against
Trypanosoma cruzi
acute lethal infection by decreasing cardiac parasite burdens
. Parasite Immunology 42:10.
Crossref
Crossref
Eric Dumonteil, Claudia Herrera, Weihong Tu, Kelly Goff, Marissa Fahlberg, Erin Haupt, Amitinder Kaur, Preston A. Marx, Jaime Ortega-Lopez, Peter J. Hotez & Maria Elena Bottazzi. (2020) Safety and immunogenicity of a recombinant vaccine against Trypanosoma cruzi in Rhesus macaques. Vaccine 38:29, pages 4584-4591.
Crossref
Crossref
Katharina Richard, Darren J. Perkins, Erin M. Harberts, Yang Song, Archana Gopalakrishnan, Kari Ann Shirey, Wendy Lai, Alexandra Vlk, Anup Mahurkar, Shreeram Nallar, Lynn D. Hawkins, Robert K. Ernst & Stefanie N. Vogel. (2020) Dissociation of TRIF bias and adjuvanticity. Vaccine 38:27, pages 4298-4308.
Crossref
Crossref
Zhi-Biao Wang & Jing Xu. (2020) Better Adjuvants for Better Vaccines: Progress in Adjuvant Delivery Systems, Modifications, and Adjuvant–Antigen Codelivery. Vaccines 8:1, pages 128.
Crossref
Crossref
Alla Zamyatina & Sebastian Strobl. 2020. Recent Trends in Carbohydrate Chemistry. Recent Trends in Carbohydrate Chemistry
51
102
.
Fang Yang & Thomas R. Kosten. (2019) Psychopharmacology: neuroimmune signaling in psychiatric disease-developing vaccines against abused drugs using toll-like receptor agonists. Psychopharmacology 236:10, pages 2899-2907.
Crossref
Crossref
Rebecca S. Rudicell, Marie Garinot, Masaru Kanekiyo, Heather D. Kamp, Kurt Swanson, Te-hui Chou, Shujia Dai, Olivier Bedel, Daniel Simard, Rebecca A. Gillespie, Kanwen Yang, Michael Reardon, Luis Z. Avila, Magnus Besev, Pradeep K. Dhal, Ram Dharanipragada, Lingyi Zheng, Xiaochu Duan, Joshua Dinapoli, Thorsten U. Vogel, Harry Kleanthous, John R. Mascola, Barney S. Graham, Jean Haensler, Chih-Jen Wei & Gary J. Nabel. (2019) Comparison of adjuvants to optimize influenza neutralizing antibody responses. Vaccine 37:42, pages 6208-6220.
Crossref
Crossref
Shweta Arora, Shaniya Ahmad, Rasha Irshad, Yamini Goyal, Sahar Rafat, Neha Siddiqui, Kapil Dev, Mohammad Husain, Shakir Ali, Anant Mohan & Mansoor Ali Syed. (2019) TLRs in pulmonary diseases. Life Sciences 233, pages 116671.
Crossref
Crossref
Jinju Yang, Hongwei Zhang, Ziwei Zhu, Yadan Gao, Benqiong Xiang & Qun Wei. (2019) The immunostimulatory effects and pro‐apoptotic activity of rhCNB against Lewis lung cancer is mediated by Toll‐like receptor 4. Cancer Medicine 8:9, pages 4441-4453.
Crossref
Crossref
Meagan A. Barry, Leroy Versteeg, Qian Wang, Jeroen Pollet, Bin Zhan, Fabian Gusovsky, Maria Elena Bottazzi, Peter J. Hotez & Kathryn M. Jones. (2019) A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection. PLOS Neglected Tropical Diseases 13:5, pages e0007413.
Crossref
Crossref
Reetakshi Arora, Colin N. Haile, Therese A. Kosten, Yan Wu, Muthu Ramakrishnan, Lynn D. Hawkins, Frank M. Orson & Thomas R. Kosten. (2019) Preclinical efficacy of an anti-methamphetamine vaccine using E6020 adjuvant. The American Journal on Addictions 28:2, pages 119-126.
Crossref
Crossref
Vinita Mishra & Chandramani Pathak. (2019) Human Toll-Like Receptor 4 (hTLR4): Structural and functional dynamics in cancer. International Journal of Biological Macromolecules 122, pages 425-451.
Crossref
Crossref
Kevin L. Williams. 2019. Endotoxin Detection and Control in Pharma, Limulus, and Mammalian Systems. Endotoxin Detection and Control in Pharma, Limulus, and Mammalian Systems
95
155
.
Roberta Olmo Pinheiro, Veronica Schmitz, Bruno Jorge de Andrade Silva, André Alves Dias, Beatriz Junqueira de Souza, Mayara Garcia de Mattos Barbosa, Danuza de Almeida Esquenazi, Maria Cristina Vidal Pessolani & Euzenir Nunes Sarno. (2018) Innate Immune Responses in Leprosy. Frontiers in Immunology 9.
Crossref
Crossref
Blake Alan Scott, Mark YarchoanElizabeth M. Jaffee. (2018) Prophylactic Vaccines for Nonviral Cancers. Annual Review of Cancer Biology 2:1, pages 195-211.
Crossref
Crossref
Alla Zamyatina. (2018) Aminosugar-based immunomodulator lipid A: synthetic approaches. Beilstein Journal of Organic Chemistry 14, pages 25-53.
Crossref
Crossref
Nathalie Garçon & Martin Friede. 2018. Plotkin's Vaccines. Plotkin's Vaccines
61
74.e4
.
Joseph R. FrancicaDaniel E. ZakCaitlyn LindeEmilio SienaCarrie JohnsonMichal JuraskaNicole L. YatesBronwyn GunnEnnio De GregorioBarbara J. FlynnNicholas M. ValiantePadma MalyalaSusan W. BarnettPampi SarkarManmohan SinghSiddhartha JainMargaret Ackerman, Munir AlamGuido FerrariAndres Salazar, Georgia D. TomarasDerek T. O’HaganAlan AderemGalit AlterRobert A. Seder. (2017) Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs. Blood Advances 1:25, pages 2329-2342.
Crossref
Crossref
Jamie S. Church, Lindsay M. Milich, Jessica K. Lerch, Phillip G. Popovich & Dana M. McTigue. (2017) E6020, a synthetic TLR4 agonist, accelerates myelin debris clearance, Schwann cell infiltration, and remyelination in the rat spinal cord. Glia 65:6, pages 883-899.
Crossref
Crossref
Jeroen Pollet, Leroy Versteeg, Wanderson Rezende, Ulrich Strych, Fabian Gusovsky, Peter J. Hotez & Maria Elena Bottazzi. (2017) A simple fluorescence-based assay for quantification of the Toll-Like Receptor agonist E6020 in vaccine formulations. Vaccine 35:10, pages 1410-1416.
Crossref
Crossref
C.B. Fox, D. Carter, R.M. Kramer, A.M. Beckmann & S.G. Reed. 2017. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
105
127
.
Jason D. Marshall, Darren S. Heeke, Eileen Rao, Sean K. Maynard, David Hornigold, Christopher McCrae, Neil Fraser, Andrey Tovchigrechko, Li Yu, Nicola Williams, Sarah King, Martin E. Cooper, Adeline M. Hajjar & Jennifer C. Woo. (2016) A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 Activation. PLOS ONE 11:10, pages e0164632.
Crossref
Crossref
Tom Y.-H. Wu. (2016) Strategies for designing synthetic immune agonists. Immunology 148:4, pages 315-325.
Crossref
Crossref
Matthias GieseMatthias Giese. 2016. Introduction to Molecular Vaccinology. Introduction to Molecular Vaccinology
145
163
.
Jean Haensler, Patricia Probeck, Jin Su, Fabienne Piras, François Dalençon, Jean-François Cotte, Véronique Chambon, Shehzad M. Iqbal, Lynn Hawkins & Nicolas Burdin. (2015) Design and preclinical characterization of a novel vaccine adjuvant formulation consisting of a synthetic TLR4 agonist in a thermoreversible squalene emulsion. International Journal of Pharmaceutics 486:1-2, pages 99-111.
Crossref
Crossref
Juhienah K. Khalaf, William S. Bowen, Hélène G. Bazin, Kendal T. Ryter, Mark T. Livesay, Jon R. Ward, Jay T. Evans & David A. Johnson. (2015) Characterization of TRIF selectivity in the AGP class of lipid A mimetics: Role of secondary lipid chains. Bioorganic & Medicinal Chemistry Letters 25:3, pages 547-553.
Crossref
Crossref
Karran A. Phillips, David H. Epstein & Kenzie L. Preston. (2014) Psychostimulant addiction treatment. Neuropharmacology 87, pages 150-160.
Crossref
Crossref
Florian Adanitsch, Simon Ittig, Johannes Stöckl, Alja Oblak, Mira Haegman, Roman Jerala, Rudi Beyaert, Paul Kosma & Alla Zamyatina. (2014) Development of αGlcN(1↔1)αMan-Based Lipid A Mimetics as a Novel Class of Potent Toll-like Receptor 4 Agonists. Journal of Medicinal Chemistry 57:19, pages 8056-8071.
Crossref
Crossref
Tomoko Hayashi, Brian Crain, Shiyin Yao, Christa D. Caneda, Howard B. Cottam, Michael Chan, Maripat Corr & Dennis A. Carson. (2014) Novel Synthetic Toll-Like Receptor 4/MD2 Ligands Attenuate Sterile Inflammation. Journal of Pharmacology and Experimental Therapeutics 350:2, pages 330-340.
Crossref
Crossref
Shanjana Awasthi. (2014) Toll-Like Receptor-4 Modulation for Cancer Immunotherapy. Frontiers in Immunology 5.
Crossref
Crossref
Ji Eun Han, Seo Ri Wui, Kwang Sung Kim, Yang Je Cho, Wan Je Cho & Na Gyong Lee. (2014) Characterization of the Structure and Immunostimulatory Activity of a Vaccine Adjuvant, De-O-Acylated Lipooligosaccharide. PLoS ONE 9:1, pages e85838.
Crossref
Crossref
Jesús Arenas. 2014. Molecular Vaccines. Molecular Vaccines
527
536
.
Nathalie. Garçon, Stanley. Hem & Martin. Friede. 2013. Vaccines. Vaccines
58
70
.
Dipshikha Chakravortty, Amit Lahiri & Priyanka Das. 2012. Vaccinology. Vaccinology
393
400
.
Derek T. O'Hagan & Andreas Wack. 2012. Vaccinology. Vaccinology
348
360
.
Heather L. Wilson, Scott Napper, George K. Mutwiri, Sylvia van Drunen Littel‐van den Hurk, Hugh Townsend, Lorne A. Babiuk, Andrew A. Potter & Volker Gerdts. 2012. Vaccinology. Vaccinology
13
28
.
Ji Eun Han, Seo Ri Wui, Shin Ae Park, Na Gyong Lee, Kwang Sung Kim, Yang Je Cho, Hyoung Jin Kim & Hong-Jin Kim. (2012) Comparison of the immune responses to the CIA06-adjuvanted human papillomavirus L1 VLP vaccine with those against the licensed HPV vaccine Cervarix™ in mice. Vaccine 30:28, pages 4127-4134.
Crossref
Crossref
William S. BowenLaurie A. MinnsDavid A. JohnsonThomas C. MitchellMelinda M. HuttonJay T. Evans. (2012) Selective TRIF-Dependent Signaling by a Synthetic Toll-Like Receptor 4 Agonist. Science Signaling 5:211.
Crossref
Crossref
Shangzi Wang, Igor A. Astsaturov, Catherine A. Bingham, Kenneth M. McCarthy, Margaret von Mehren, Wei Xu, R. Katherine Alpaugh, Yong Tang, Bruce A. Littlefield, Lynn D. Hawkins, Sally T. Ishizaka & Louis M. Weiner. (2011) Effective antibody therapy induces host-protective antitumor immunity that is augmented by TLR4 agonist treatment. Cancer Immunology, Immunotherapy 61:1, pages 49-61.
Crossref
Crossref
Tracey J. Coffey & Dirk Werling. (2010) Therapeutic targeting of the innate immune system in domestic animals. Cell and Tissue Research 343:1, pages 251-261.
Crossref
Crossref
Gael Auray, Marina R. Facci, Jill van Kessel, Rachelle Buchanan, Lorne A. Babiuk & Volker Gerdts. (2010) Differential activation and maturation of two porcine DC populations following TLR ligand stimulation. Molecular Immunology 47:11-12, pages 2103-2111.
Crossref
Crossref
Pamela L. Beatty, Sowmya Narayanan, Jean Gariépy, Sarangarajan Ranganathan & Olivera J. Finn. (2010) Vaccine against MUC1 Antigen Expressed in Inflammatory Bowel Disease and Cancer Lessens Colonic Inflammation and Prevents Progression to Colitis-Associated Colon Cancer. Cancer Prevention Research 3:4, pages 438-446.
Crossref
Crossref
Mark Spyvee, Lynn D. Hawkins & Sally T. Ishizaka. 2010.
191
207
.
Christopher B. Fox, Martin Friede, Steven G. Reed & Gregory C. Ireton. 2010. Endotoxins: Structure, Function and Recognition. Endotoxins: Structure, Function and Recognition
303
321
.
Kaustabh K. Maiti, Michael DeCastro, Abu-Baker M. Abdel-Aal El-Sayed, Matthew I. Foote, Margreet A. Wolfert & Geert-Jan Boons. (2010) Chemical Synthesis and Proinflammatory Responses of Monophosphoryl Lipid A Adjuvant Candidates. European Journal of Organic Chemistry 2010:1, pages 80-91.
Crossref
Crossref
Leslie E. Walker, Lo Vang, Xuefei Shen, Brian D. Livingston, Penny Post, Alessandro Sette, C. Steven Godin & Mark J. Newman. (2009) Design and preclinical development of a recombinant protein and DNA plasmid mixed format vaccine to deliver HIV-derived T-lymphocyte epitopes. Vaccine 27:50, pages 7087-7095.
Crossref
Crossref
R. N. COLER, D. CARTER, M. FRIEDE & S. G. REED. (2009) Adjuvants for malaria vaccines. Parasite Immunology 31:9, pages 520-528.
Crossref
Crossref
Derek T. O’Hagan & Ennio De Gregorio. (2009) The path to a successful vaccine adjuvant – ‘The long and winding road’. Drug Discovery Today 14:11-12, pages 541-551.
Crossref
Crossref
Barbara C. Baudner, Vanessa Ronconi, Daniele Casini, Marco Tortoli, Jina Kazzaz, Manmohan Singh, Lynn D. Hawkins, Andreas Wack & Derek T. O’Hagan. (2009) MF59 Emulsion Is an Effective Delivery System for a Synthetic TLR4 Agonist (E6020). Pharmaceutical Research 26:6, pages 1477-1485.
Crossref
Crossref
Amit Lahiri, Priyanka Das & Dipshikha Chakravortty. (2008) Engagement of TLR signaling as adjuvant: Towards smarter vaccine and beyond. Vaccine 26:52, pages 6777-6783.
Crossref
Crossref
Daryl S. Spinner, In Soo Cho, Seung Yong Park, Jae Il Kim, Harry C. Meeker, Xuemin Ye, Giuseppe LaFauci, Daniel J. Kerr, Michael J. Flory, Bo Sook Kim, Regina B. Kascsak, Thomas Wisniewski, William R. Levis, Georgia B. Schuller-Levis, Richard I. Carp, Eunkyue Park & Richard J. Kascsak. (2008) Accelerated Prion Disease Pathogenesis in Toll-Like Receptor 4 Signaling-Mutant Mice. Journal of Virology 82:21, pages 10701-10708.
Crossref
Crossref